The therapeutic role of nutraceuticals targeting the Nrf2/HO‐1 signaling pathway in liver cancer

KS Alharbi, WH Almalki, M Albratty… - Journal of Food …, 2022 - Wiley Online Library
Liver cancer (LC) is the most common cause of cancer death in the United States and the
fifth most common globally. The overexpression of nuclear factor E2 related factor 2 (Nrf2) …

Molecular targets and signaling pathways of microRNA-122 in hepatocellular carcinoma

KH Chun - Pharmaceutics, 2022 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the leading global causes of cancer mortality.
MicroRNAs (miRNAs) are small interfering RNAs that alleviate the levels of protein …

Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation

H Jin, C Zhang, M Zwahlen, K Von Feilitzen… - Nature …, 2023 - nature.com
Cell lines are valuable resources as model for human biology and translational medicine. It
is thus important to explore the concordance between the expression in various cell lines vis …

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms

AC Puhl, EJ Fritch, TR Lane, LV Tse, BL Yount… - ACS …, 2021 - ACS Publications
Severe acute respiratory coronavirus 2 (SARS-CoV-2) is a newly identified virus that has
resulted in over 2.5 million deaths globally and over 116 million cases globally in March …

Titration of RAS alters senescent state and influences tumour initiation

ASL Chan, H Zhu, M Narita, LD Cassidy, ARJ Young… - Nature, 2024 - nature.com
Oncogenic RAS-induced senescence (OIS) is an autonomous tumour suppressor
mechanism associated with premalignancy,. Achieving this phenotype typically requires a …

[HTML][HTML] Synergistic effect of IFN-γ and IL-1β on PD-L1 expression in hepatocellular carcinoma

Y Numata, N Akutsu, K Ishigami, H Koide… - … and Biophysics Reports, 2022 - Elsevier
Immunotherapy using anti-programmed death 1 ligand 1 (PD-L1) antibodies has shown
clinical efficacy against hepatocellular carcinoma (HCC) and is recognized as the first-line …

EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma

R Yang, X Li, Y Wu, G Zhang, X Liu, Y Li, Y Bao… - Oncogene, 2020 - nature.com
Cancer metabolism research has recently been revived and its focus expanded from
glucose and the Warburg's effects on other nutrients, such as glutamine. The underlying …

Recent advance of ATP citrate lyase inhibitors for the treatment of cancer and related diseases

JJ Liang, XF Zhou, H Long, CY Li, J Wei, XQ Yu… - Bioorganic …, 2024 - Elsevier
ATP citrate lyase (ACLY), a strategic metabolic enzyme that catalyzes the glycolytic to lipidic
metabolism, has gained increasing attention as an attractive therapeutic target for …

In vitro cell toxicity and intracellular uptake of doxorubicin exposed as a solution or liposomes: Implications for treatment of hepatocellular carcinoma

F Kullenberg, O Degerstedt, C Calitz, N Pavlović… - Cells, 2021 - mdpi.com
Cytostatic effects of doxorubicin in clinically applied doses are often inadequate and limited
by systemic toxicity. The main objective of this in vitro study was to determine the anti …

A Mitochondrial Dysfunction and Oxidative Stress Pathway‐Based Prognostic Signature for Clear Cell Renal Cell Carcinoma

Y Wu, X Zhang, X Wei, H Feng, B Hu… - Oxidative Medicine …, 2021 - Wiley Online Library
Mitochondria not only are the main source of ATP synthesis but also regulate cellular redox
balance and calcium homeostasis. Its dysfunction can lead to a variety of diseases and …